|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Operating expenses | ||
| Research and development | ||
| General and administrative | ||
| Total operating expenses | ||
| Loss from operations | ||
| Interest and other income, net | ||
| Net loss | ||
| Unrealized gain on marketable securities | ||
| Reclassification of net gains included in net loss | ||
| Total other comprehensive gain (loss) | ||
| Total comprehensive loss | ||
| Net loss attributable to common stockholders | ||
| Net loss per common share, basic | ||
| Net loss per common share, diluted | ||
| Weighted average number of common shares outstanding used in computation of net loss per common share, basic | ||
| Weighted average number of common shares outstanding used in computation of net loss per common share, diluted |
Loading...
